Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2025-12-24 @ 3:27 PM
NCT ID:
NCT01549392
Eligibility Criteria:
Inclusion Criteria:
* Histological diagnosis of glioblastoma with clinical or radiological evidence of progression as indicated by the RANO criteria 19
* Previous radiation and temozolomide chemotherapy
* Patients must be receiving Avastin chemotherapy as second-line treatment if in the Avastin group
* Study-specific consent
Exclusion Criteria:
* Failure to meet inclusion criteria
* Pregnant or lactating patients
* Allergy to iodine or CT contrast precludes DECT component of study
* Claustrophobia precludes MR Spectroscopy component of study
* Internal metal which would preclude an MRI scan
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT01549392
Study Brief:
Protocol Section:
NCT01549392